Investigating the link between COVID-19 and diabetes development
CODA: COvid and Diabetes Assessment
This study is looking at how COVID-19 might affect the development and worsening of Type 1 and Type 2 diabetes, and it's inviting both kids and adults who have recently been diagnosed with diabetes—whether or not they've had COVID-19—to join in and share their experiences.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11111637 on NIH RePORTER |
What this research studies
This research focuses on understanding how COVID-19 infection may contribute to the onset and progression of Type 1 and Type 2 diabetes. It aims to recruit a diverse group of patients, both adults and children, who have recently been diagnosed with diabetes and have either had a known COVID-19 infection or not. The study will utilize a national network to identify potential participants through electronic health records and will engage them through various communication methods for ongoing surveys. By analyzing the data collected, researchers hope to uncover important biological processes linking COVID-19 and diabetes.
Who could benefit from this research
Good fit: Ideal candidates include individuals aged 0-11 and 21+ who have been diagnosed with Type 1 or Type 2 diabetes within the last three months and have had a known COVID-19 infection.
Not a fit: Patients who have not been diagnosed with diabetes or those who have not had a COVID-19 infection in the specified timeframe may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and management of diabetes in patients who have had COVID-19.
How similar studies have performed: Other research has indicated a potential link between viral infections and diabetes, suggesting that this approach may yield valuable insights.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Rothman, Russell L. — Vanderbilt University Medical Center
- Study coordinator: Rothman, Russell L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.